STUDY: Myelodysplastic Syndrome Exome Sequnecing

Study Description

Cancer is driven by mutation. Illumina GA massively parallel sequencing technology will be applied to Agilent exome hybridisation capture... Show More

Study Accession Alternative Stable ID type
EGAS00001000089 Other

Publications

21995386